Hua Medicine (Shanghai) Ltd.
HUMDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$302.99M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $302.99 Million |
|---|---|
| Enterprise Value | $-415,554,962.00 |
| Earnings per Share | $1.12 |
| Beta | 0.77 |
| Outstanding Shares | 997,988,916 |
Return
| Return on Equity | 97.73% |
|---|---|
| Return on Assets | 64.03% |
| Return on Invested Capital | -30.22% |
Valuation & Multiples
| P/E Ratio | -18.73 |
|---|---|
| PEG | 18.27 |
| Price to Sales | 0.3 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.51 |
| Enterprise Value to EBIT | -4.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
$-0.03
Consensus analyst estimateRevenue Estimate
$73.68 M
Consensus analyst estimateNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
$0.08
Consensus analyst estimateRevenue Estimate
$111.53 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Hua Medicine (Shanghai) Ltd.
424 employees
CEO: Li Chen
Hua Medicine (Shanghai) Ltd., a biopharmaceutical enterprise established in 2011 and headquartered in Beijing, China, specializes in the clinical development of novel therapeutic solutions, with a primary focus on addressing diabetes wit...